Therapeutic Solutions International (TSOI) Stock Price, News & Analysis

Company Overview

Therapeutic Solutions International, Inc. is a biotechnology company focused on developing immunotherapies, stem-cell-based treatments and other products intended to address cancer, infectious diseases, autoimmune conditions and inflammation. Its activities have included research and development, product commercialization and collaborations involving regenerative medicine and immune-system modulation.

The company has promoted a portfolio that includes the JadiCell stem-cell platform, which is being studied for potential therapeutic applications, as well as immune-support and nutraceutical products such as QuadraMune. Therapeutic Solutions International has also described work involving vaccine and cancer-immunotherapy technologies, although the development and commercial status of individual programs may vary.

Therapeutic Solutions International is headquartered in the United States and serves customers and research markets primarily through its U.S.-based operations and online sales channels. Timothy L. Dixon has been identified in company materials as its president and chief executive officer. The company has operated under its current name after previously being associated with the Entest Group, reflecting its evolution toward biotechnology and therapeutic development.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 20.24 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:TSOI
• CIK: 1419051
• Web: therapeuticsolutionsint.com
• Phone: (760) 295-7208
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A